News
Biogen to Invest $2 Billion More in North Carolina
(Reuters) -Drugmaker Biogen said on Monday it will invest an additional $2 billion in its existing manufacturing footprint in North Carolina's Research Triangle Park. The company has invested about $10 billion in its North Carolina manufacturing to date. Copyright 2025 Thomson Reuters.
Biogen to boost US manufacturing footprint with $2bn North Carolina investment
Biogen has unveiled plans to invest an additional $2bn in its existing manufacturing footprint in North Carolina, US. The upcoming investment in the state’s Research Triangle Park (RTP), where Biogen first broke ground in 1995, is aimed at fuelling the “continued advancement” of the company’s late-stage clinical pipeline.
Biogen Inc. is investing $2 billion in its North Carolina RTP site, expanding manufacturing amid tariff talks.
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date ...
The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will increase.
GlobalData on MSN2d
Biogen to invest further $2bn in North Carolina’s Research Triangle ParkBiogen has announced plans to invest an additional $2bn in Research Triangle Park (RTP) in the US state of North Carolina.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback